Dr. John Matthew Lee, MD

Dr. Lee practices at Texas Health Physicians Group in Kaufman, Texas.

Dr. Lee's NPI, 1679764948, was assigned on August 5, 2007. Dr. Lee graduated from Keck School of Medicine of USC in 2007. Dr. Lee's Texas license number on file is N3821.

Dr. Lee's primary practice is Texas Health Physicians Group, at 874 Ed Hall Dr, Kaufman, TX 75142 in Kaufman County. The practice phone is (214) 860-6300.

Dr. Lee's primary practice is Texas Health Physicians Group in Kaufman, Texas. Dr. Lee is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Lee to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Lee is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Lee's licenses on file in 2 states: Texas and California.

Dmand AI lists angioplasty, cardiac catheterization, endocarditis and leg revascularization among the conditions Dr. Lee treats.

CMS data shows 3,335 Medicare services from Dr. Lee across 27 procedure codes in 2024, for 1,228 Medicare patients. Medicare paid $212,100 for them.

CMS counts 1,228 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 512 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 69, with 46% women.

In 2024, Dr. Lee wrote 5,928 Medicare Part D claims for 925 patients. 85% of them were for generic drugs. CMS names the drug for 5,734 of them, across 52 drugs with 11 or more claims each, at $932,833 in total drug cost. In 2023, CMS named 5,009 claims across 51 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Lee for performance year 2024, reported individually. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth. CMS counts 39 procedures of coronary angioplasty and stenting by Dr. Lee, more than 75% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Lee in 2018. Dr. Lee's most frequent co-authors are Kenneth J J. Chang, MD, Ke-Qin Hu, MD and Kathleen A. Kennedy, MD.

CMS Open Payments shows 398 general payments to Dr. Lee from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Boston Scientific Corporation paid the most, $3,968.

Dr. Lee graduated from Keck School of Medicine of USC in 2007.

Dr. Lee is in network with 22 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.